Akèy › Anplwayè › FibroGen, Inc.
FibroGen, Inc.: Salè H-1B ak pajon
FibroGen, Inc. depoze 15 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 14. Medyèn salè yo ofri a: $134,180.
Èske FibroGen, Inc. pajone visa H-1B?
FibroGen, Inc. depoze 15 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou May 29, 2024. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| China Contracts Manager | 3 | $143,562 |
| Clinical Trial Manager | 2 | $147,628 |
| Senior Manager, Clinical Programming | 1 | $179,878 |
| Sr. Director, Forecasting & Analytics | 1 | $227,635 |
| IT Business Systems Analyst | 1 | $116,272 |
| Clinical Trial Assistant | 1 | $86,195 |
| Associate Scientist, Cell Line Development | 1 | $111,072 |
| Manager, Clinical Quality Assurance | 1 | $116,355 |
| Manager, Statistical Programming, Biometrics | 1 | $137,779 |
| Sr. Manager, IT | 1 | $168,035 |
| SAP Technical Analyst | 1 | $119,642 |
| Research Scientist/Senior Scientist of Analytical Developmen | 1 | $127,878 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 4 | $143,562 |
| FY2024 | 8 | $134,180 |
| FY2025 | 3 | $119,642 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Natural Sciences Managers3
- Regulatory Affairs Managers3
- Data Scientists1
- Operations Research Analysts1
- Medical Scientists, Except Epidemiologists1
- Biochemists and Biophysicists1
- Regulatory Affairs Specialists1
- Management Analysts1
- Computer Systems Analysts1
- Database Architects1
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Sr. Manager, IT | $168,035 | Plano, TX | May 29, 2024 | Jun 15, 2024 | Certifye, apre retire |
| SAP Technical Analyst | $119,642–$171,300 Nivo II | Atlanta, GA | May 3, 2024 | Oct 1, 2024 | Certifye, apre retire |
| China Contracts Manager | $143,562–$170,000 Nivo II | San Francisco, CA | Jan 27, 2023 | Feb 7, 2023 | Certifye |
| China Contracts Manager | $143,562–$170,000 Nivo II | San Francisco, CA | Jan 17, 2023 | Feb 1, 2023 | Certifye, apre retire |
| China Contracts Manager | $143,562–$170,000 Nivo II | San Francisco, CA | Jan 17, 2023 | Feb 1, 2023 | Retire |
| Associate Scientist, Cell Line Development | $111,072–$115,000 Nivo II | San Francisco, CA | Jan 5, 2023 | Jan 23, 2023 | Certifye, apre retire |
| Clinical Trial Manager | $164,674–$170,357 E-3 · Nivo II | New York, NY | Dec 22, 2022 | Feb 1, 2023 | Certifye, apre retire |
| Senior Manager, Clinical Programming | $179,878–$205,000 Nivo IV | San Francisco, CA | Dec 9, 2022 | Jan 16, 2023 | Certifye, apre retire |
| Sr. Director, Forecasting & Analytics | $227,635–$260,000 Nivo IV | Montclair, NJ | Nov 16, 2022 | Dec 15, 2022 | Certifye, apre retire |
| IT Business Systems Analyst | $116,272–$133,256 Nivo IV | Frisco, TX | Oct 28, 2022 | Nov 7, 2022 | Certifye |
| Clinical Trial Assistant | $86,195–$90,000 Nivo I | San Francisco, CA | Oct 19, 2022 | Nov 15, 2022 | Certifye, apre retire |
| Research Scientist/Senior Scientist of Analytical Developmen | $127,878–$130,000 Nivo IV | San Francisco, CA | May 2, 2022 | Oct 1, 2022 | Certifye, apre retire |
| Clinical Trial Manager | $130,582–$163,750 Nivo I | San Francisco, CA | Feb 10, 2022 | Feb 22, 2022 | Certifye, apre retire |
| Manager, Statistical Programming, Biometrics | $137,779–$168,920 Nivo IV | San Francisco, CA | Jan 31, 2022 | Apr 30, 2022 | Certifye, apre retire |
| Manager, Clinical Quality Assurance | $116,355–$135,000 Nivo IV | San Francisco, CA | Jul 23, 2021 | Jul 29, 2021 | Certifye, apre retire |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).